Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us?

IF 5.7 2区 医学 Q1 ONCOLOGY
Marion Piñeros, Jerome Vignat, Murielle Colombet, Mathieu Laversanne, Catterina Ferreccio, Katy Heise, Sharayu Mhatre, Jill Koshiol, Freddie Bray
{"title":"Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us?","authors":"Marion Piñeros,&nbsp;Jerome Vignat,&nbsp;Murielle Colombet,&nbsp;Mathieu Laversanne,&nbsp;Catterina Ferreccio,&nbsp;Katy Heise,&nbsp;Sharayu Mhatre,&nbsp;Jill Koshiol,&nbsp;Freddie Bray","doi":"10.1002/ijc.35232","DOIUrl":null,"url":null,"abstract":"<p>On a global scale, gallbladder cancer is a relatively rare cancer with a striking variability in incidence across countries and world regions. We examined recent geographic variations worldwide based on national gallbladder cancer incidence estimates for the year 2022 from the GLOBOCAN database for 185 countries alongside recorded incidence data from the most recent volume of Cancer Incidence in Five Continents. In 2022, 122,491 new gallbladder cancer cases and 89,055 deaths were estimated to occur worldwide, of which 64.5% and 64.7% respectively were among females. The highest reported rates (ASR per 100,000) were in subpopulations of Northeastern regions of India and Southern Chile in both males (ASR of 6.1 and 5.3, respectively) and in females, though rates were two times higher than males (ASR of 14.9 and 15.4). The lowest incidence rates were reported in subpopulations of Uganda for males and South Africa for females (0.21 and 0.14, respectively). Recorded gallbladder cancer incidence rates among subnational populations within countries differed considerably from their respective national estimates and revealed a 100-fold variation in gallbladder cancer, highlighting the importance of subnational population-based cancer registry data in pinpointing areas of high risk, driving research and prioritizing tailored public health actions.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":"156 7","pages":"1358-1368"},"PeriodicalIF":5.7000,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ijc.35232","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

On a global scale, gallbladder cancer is a relatively rare cancer with a striking variability in incidence across countries and world regions. We examined recent geographic variations worldwide based on national gallbladder cancer incidence estimates for the year 2022 from the GLOBOCAN database for 185 countries alongside recorded incidence data from the most recent volume of Cancer Incidence in Five Continents. In 2022, 122,491 new gallbladder cancer cases and 89,055 deaths were estimated to occur worldwide, of which 64.5% and 64.7% respectively were among females. The highest reported rates (ASR per 100,000) were in subpopulations of Northeastern regions of India and Southern Chile in both males (ASR of 6.1 and 5.3, respectively) and in females, though rates were two times higher than males (ASR of 14.9 and 15.4). The lowest incidence rates were reported in subpopulations of Uganda for males and South Africa for females (0.21 and 0.14, respectively). Recorded gallbladder cancer incidence rates among subnational populations within countries differed considerably from their respective national estimates and revealed a 100-fold variation in gallbladder cancer, highlighting the importance of subnational population-based cancer registry data in pinpointing areas of high risk, driving research and prioritizing tailored public health actions.

胆囊癌发病率的全球差异:记录数据和国家估算数据告诉我们什么?
在全球范围内,胆囊癌是一种相对罕见的癌症,其发病率在不同国家和地区之间存在显著差异。我们根据 GLOBOCAN 数据库中 185 个国家 2022 年的胆囊癌发病率估计值,以及最新一卷《五大洲癌症发病率》中记录的发病率数据,研究了全球近期的地域差异。据估计,2022年全球将新增122,491例胆囊癌病例和89,055例死亡病例,其中女性病例和死亡病例分别占64.5%和64.7%。在印度东北部地区和智利南部的亚人群中,男性的发病率(ASR/100,000)最高(分别为 6.1 和 5.3),而女性的发病率(ASR/100,000)是男性的两倍(分别为 14.9 和 15.4)。在乌干达和南非的亚人群中,男性和女性的发病率分别最低(分别为 0.21 和 0.14)。各国国内国家以下人口中记录的胆囊癌发病率与各自国家的估计值相差很大,显示胆囊癌的发病率相差 100 倍,这突出了国家以下人口癌症登记数据在确定高风险地区、推动研究和优先采取有针对性的公共卫生行动方面的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
13.40
自引率
3.10%
发文量
460
审稿时长
2 months
期刊介绍: The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信